288 related articles for article (PubMed ID: 6441963)
21. [Infection resistance in hemoblastoses, functional studies on leukocyte mobilization in healthy and sick subjects].
Senn H
Exp Med Pathol Klin; 1972; 36():1-110. PubMed ID: 4559715
[No Abstract] [Full Text] [Related]
22. [Antibacterial immunity in hematopoietic proliferative diseases].
Serafiŕska P; Lewicka T; Cassic J
Acta Haematol Pol; 1973; 4(1):55-64. PubMed ID: 4522084
[No Abstract] [Full Text] [Related]
23. [Membrane markers in chronic lymphoproliferative diseases].
Matutes E; San Miguel JF; Catovsky D
Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
[No Abstract] [Full Text] [Related]
24. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
Mantovani G; Petrini MT; Tognella S; Grifoni V
Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
[No Abstract] [Full Text] [Related]
25. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal immunoglobulins and B cell lymphoproliferative disorders.
Sugai S; Takiguchi T; Konda S
Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1604-15. PubMed ID: 6335808
[No Abstract] [Full Text] [Related]
27. Immune responsiveness and hematologic malignancy in the elderly.
Fernandez G; Schwartz JM
Med Clin North Am; 1976; 60(6):1253-71. PubMed ID: 790049
[No Abstract] [Full Text] [Related]
28. [The capacity for phagocytosis of granulocytes in lymphoproliferative diseases].
Eggers G; Breuel K; Kruse H; Blau HJ
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):290-3. PubMed ID: 6205952
[No Abstract] [Full Text] [Related]
29. Hemoglobin abnormalities in neoplastic hematological disorders.
Walker IR; Ali MA
Can Med Assoc J; 1973 Apr; 108(7):843-7. PubMed ID: 4513360
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy of haematological malignancies. Prognostic significance.
Klener P
Acta Univ Carol Med Monogr; 1979; 90():7-127. PubMed ID: 400423
[No Abstract] [Full Text] [Related]
31. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
Do TP; Petrányi G; Hollán Z
Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
[No Abstract] [Full Text] [Related]
32. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of carcinoembryonic antigen (CEA) in patients with neoplasms and hematologic diseases].
Bulfoni A
Arch Sci Med (Torino); 1981; 138(4):449-54. PubMed ID: 7340729
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic and pathogenetic significance of some cytogenetic and cythochemical findings (leukocyte alkaline phosphatase) in systemic hemopathies with myeloproliferative tendencies].
Cacciola E; Giustolisi R
Haematologica; 1970; 55(5):311-32. PubMed ID: 4995787
[No Abstract] [Full Text] [Related]
36. [Myelofibrosis during hematologic diseases. Apropos of 402 cases].
Devred C; Diebold J
Sem Hop; 1974 May; 50(24):1625-34. PubMed ID: 4373832
[No Abstract] [Full Text] [Related]
37. [Immunoglobulin composition of the blood in hemolymphoblastosis].
Medina F; Tognella S
Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
[No Abstract] [Full Text] [Related]
38. Clq binding circulating immune complexes in multiple sclerosis patients and their first-degree relatives: a distinctive immunological feature between sporadic and familial cases.
Trouillas P; Vincent C; Revillard JV
J Clin Lab Immunol; 1980 Sep; 4(2):77-81. PubMed ID: 7441712
[TBL] [Abstract][Full Text] [Related]
39. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic studies in the chronic myeloproliferative syndrome.
Kiossoglou KA; Mitus WJ; Dameshek W
Blood; 1966 Aug; 28(2):241-52. PubMed ID: 5222584
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
